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Malaria, the disease caused by Plasmodium spp. infection, remains
a major global cause of morbidity and mortality. Host protection
from malaria relies on immune-driven resistance mechanisms that
kill Plasmodium. However, these mechanisms are not sufficient per
se to avoid the development of severe forms of disease. This is
accomplished instead via the establishment of disease tolerance to
malaria, a defense strategy that does not target Plasmodium di-
rectly. Here we demonstrate that the establishment of disease
tolerance to malaria relies on a tissue damage-control mechanism
that operates specifically in renal proximal tubule epithelial cells
(RPTEC). This protective response relies on the induction of heme
oxygenase-1 (HMOX1; HO-1) and ferritin H chain (FTH) via a mecha-
nism that involves the transcription-factor nuclear-factor E2-related
factor-2 (NRF2). As it accumulates in plasma and urine during the
blood stage of Plasmodium infection, labile heme is detoxified in
RPTEC by HO-1 and FTH, preventing the development of acute kidney
injury, a clinical hallmark of severe malaria.
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Disease tolerance is an evolutionarily conserved defensestrategy against infection, first described as a central com-
ponent of plant immunity (1). Over the past decade it became ap-
parent that this defense strategy is also operational in animals,
including mammals where it confers protection against malaria (2, 3).
The blood stage of Plasmodium spp. infection is characterized
by the invasion of host red blood cells (RBC), in which this
protozoan parasite proliferates extensively, consuming up to 60–
80% of the RBC hemoglobin (HB) content (4). Plasmodium spp.
do not express a HMOX1 ortholog gene (5) and cannot catalyze
the extraction of Fe from heme, acquiring Fe via heme auto-
oxidation while also polymerizing labile heme into redox-inert
hemozoin and avoiding its cytolytic effects (6).
Once the physical integrity of infected RBC becomes compro-
mised, the remaining RBC HB content is released into plasma,
where extracellular α2β2 HB tetramers disassemble into αβ dimers
that undergo auto-oxidation, eventually releasing their noncovalently
bound heme (7). As it accumulates in plasma, labile heme is loosely
bound to plasma acceptor proteins, macromolecules, or low-
molecular-weight ligands that fail, however, to control its redox
activity (8). A fraction of the labile heme in plasma becomes
bioavailable, acting in a pathogenic manner and compromising the
establishment of disease tolerance to malaria (2, 7, 9).
Heme accumulation in plasma and urine of malaria patients is
associated with the development of acute kidney injury (AKI), a
clinical hallmark of severe malaria (10–12). Similarly, heme accu-
mulation in plasma, as a consequence of rhabdomyolysis, is also
associated with the development of AKI (13). While heme par-
takes in the pathogenesis of AKI associated with rhabdomyolysis,
whether this is the case for severe malaria has not been established.
We have previously shown that heme detoxification by the
stress-responsive enzyme HO-1 is a limiting factor in the estab-
lishment of disease tolerance to malaria (2, 7). In a similar
manner, heme detoxification by HO-1 also prevents the devel-
opment of AKI following rhabdomyolysis (13). This protective
effect requires that the Fe extracted from heme is neutralized by
the ferroxidase active FTH component of the ferritin complex
(14), establishing disease tolerance to malaria (9) and preventing
development of AKI following rhabdomyolysis (14). Here we
asked whether heme catabolism by HO-1 and Fe sequestration
by FTH act locally in the kidney to prevent the development of
AKI and establish disease tolerance to malaria.
Results
Malaria is associated with HO-1 induction in renal proximal tu-
bule epithelial cells (RPTEC). Consistent with heme accumulation
in plasma and urine of individuals developing severe forms of
malaria (9, 15), Plasmodium chabaudi chabaudi (Pcc)-infected
C57BL/6 mice accumulated heme in plasma and urine (Fig.
1A). Approximately 15% of the heme in plasma and 6% in
urine were bioavailable (Fig. 1B), as assessed using a cellular-based
heme-reporter assay (SI Appendix, Fig. S1 A and B). Heme and
labile heme concentration in urine was higher than in plasma,
suggesting that labile heme is actively excreted into urine.
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Consistent with our previous findings (9, 16), Hmox1 mRNA
(Fig. 1C) and Ho-1 protein (Fig. 1 D and E) were induced in the
liver of Pcc-infected mice. Hmox1 mRNA and Ho-1 protein were
also induced in other organs, including in the kidneys (Fig. 1 C–E
and SI Appendix, Fig. S2 A and B). Expression of Ho-1 in the kidney
was induced in the cortex and in the medulla (Fig. 1 F andG and SI
Appendix, Fig. S2A), predominantly in RPTEC (Fig. 1H and SI
Appendix, Fig. S2B). This suggests that, as it accumulates in plasma
and urine during the blood stage of Plasmodium infection, labile
heme is up taken by RPTEC, where it is catabolized by HO-1.
HO-1 expression in RPTEC is essential to establish disease
tolerance to malaria. To determine whether heme catabolism in
RPTEC is involved in the establishment of disease tolerance to
malaria, we generated Hmox1PepckΔ/Δ mice, in which Hmox1 is
deleted specifically in RPTEC (17) (SI Appendix, Fig. S2C). Pcc-
infectedHmox1PepckΔ/Δ mice succumbed to Pcc infection, compared
with control Hmox1fl/fl mice that survived and resolved the infection
(Fig. 2A). Mortality of Hmox1PepckΔ/Δ mice was not associated with
changes in parasitemia, compared with control Hmox1fl/fl mice (Fig.
2A). This suggests that heme catabolism by HO-1 in RPTEC is
essential to establish disease tolerance to malaria.
Lethality of Pcc-infected Hmox1PepckΔ/Δ mice was associated
with the development of AKI, as illustrated by the accumulation
of Lipocalin 2 (LCN2) in urine and blood urea nitrogen (BUN)
(Fig. 2B). AKI in Pcc-infected Hmox1PepckΔ/Δ mice was charac-
terized histologically by widespread acute tubular necrosis and
HB casts affecting up to 15% of the renal cortex, compared with
sparse tubular single-cell death and HB casts in control Pcc-
infected Hmox1fl/fl mice (Fig. 2C). This suggests that during
the blood stage of Plasmodium infection, the induction of heme
catabolism by HO-1 in RPTEC is essential to prevent the de-
velopment of AKI, a clinical hallmark of severe malaria (10–12).
The extent of liver damage, another clinical hallmark of severe
malaria captured in Pcc-infected mice (9, 16), was similar in in-
fected Hmox1PepckΔ/Δ vs. Hmox1fl/fl mice, as assessed serologically
(SI Appendix, Fig. S2D). This suggests that heme catabolism in
RPTEC does not counter the development of liver damage.
The complete blood count profile of Pcc-infected Hmox1PepckΔ/Δ
and Hmox1fl/fl mice was indistinguishable (SI Appendix, Table S1),
suggesting that HO-1 expression in RPTEC does not impact on
the development of hemolytic anemia during Plasmodium in-
fection. Blood neutrophilia was also similar in Pcc-infected
Hmox1PepckΔ/Δ vs. Hmox1fl/fl mice (SI Appendix, Table S1),
suggesting that HO-1 expression in RPTEC does not impact on
neutrophil activation.
Disease tolerance can be inferred from the analysis of “disease
trajectories” established by the temporal relationship of specific
host homeostatic variables versus pathogen load (18). The dis-
ease trajectories of Pcc-infected Hmox1PepckΔ/Δ mice were dis-
tinct from those of Pcc-infected control Hmox1fl/fl mice, when
analyzing body temperature vs. body weight vs. pathogen load
(Fig. 2 D and E). Differences among genotypes were statistically
significant as early as 7 d after infection, before the onset of
lethality in Hmox1PepckΔ/Δ mice (Fig. 2 D and E). This suggests
that heme catabolism by HO-1 in RPTEC is required to maintain
vital homeostatic parameters, such as body temperature and
body weight, within a dynamic range compatible with survival
from Plasmodium infection.
HO-1 expression in cell compartments other than RPTEC is
not essential to establish disease tolerance to malaria. Ubiqui-
tous deletion of Hmox1 in Hmox1R26Δ/Δ mice (SI Appendix, Fig.
S3A) recapitulated the deletion of Hmox1 specifically in RPTEC,
impairing survival to Pcc infection under pathogen loads similar
to control Hmox1fl/fl mice (SI Appendix, Fig. S3B). The disease
trajectories established by Pcc-infected were also distinct from
those of Pcc-infected control Hmox1fl/fl mice (SI Appendix, Fig.
S3 C and D). We then asked whether Hmox1 deletion in cell
compartments—where heme catabolism by HO-1 would be
expected to act in a protective manner—impaired disease tol-
erance to Pcc infection. However, Hmox1 deletion specifically in
myeloid cells of Hmox1LysMΔ/Δ mice (19), macrophages and
dendritic cells of Hmox1Cd11cΔ/Δ mice, vascular endothelial and
hematopoietic cells of Hmox1Tie2Δ/Δ mice, hepatocytes and he-
matopoietic cells of Hmox1Mx1Δ/Δ mice, or neuronal cells of
Hmox1NestinΔ/Δ mice failed to compromise disease tolerance to
Pcc infection (SI Appendix, Fig. S4 A–I). This reinforces the notion
that heme catabolism by HO-1 in RPTEC is a limiting factor in
the establishment of disease tolerance to malaria.
We then questioned whether HO-1 expression in RPTEC is
also essential to establish disease tolerance to other infectious
hemolytic conditions and tested this using an experimental
model of hemolytic Escherichia coli (clinical isolate strain
CFT073) infection (20). The lethality of E. coli CFT073 infection
was similar in Hmox1PepckΔ/Δ vs. control Hmox1fl/fl mice (SI Ap-
pendix, Fig. S5A), indicating that heme catabolism by HO-1 in
RPTEC is not essential to establish disease tolerance to hemolytic
bacterial infections.
Malaria is associated with the induction of FTH in RPTEC.
The Fe released via heme catabolism by HO-1 induces post-
transcriptionally the expression of FTH (21). Consistent with this
notion and in keeping with our previous findings (9), Fth ex-
pression was induced in the liver of Pcc-infected C57BL/6 mice,
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Fig. 1. HO-1 expression is induced in RPTEC during Plasmodium infection.
(A) Heme and (B) bioavailable heme concentration (mean ± SD) in plasma
and urine of C57BL/6 mice, not infected (NI; n = 7) or 7 d after Pcc infection
(n = 8). Data are from one experiment. (C) Hmox1 normalized to Arbp0
mRNA (mean ± SD) in brain (B), liver (Li), spleen (S), kidney (K), muscle (M),
lung (Lu), and heart (H) of C57BL/6 mice, not infected (NI; n = 3) or 7 d after
Pcc infection (n = 6). Data are from one experiment. (D) HO-1 and Gapdh
protein expression detected by Western blot in the brain (B), liver (Li), spleen
(S), kidney (K), muscle (M), lung (Lu), and heart (H) of C57BL/6 mice, not infected
(NI) or 7 d after Pcc infection. Data are representative of four mice per group in
one experiment. (E) Densitometry analysis (mean ± SD) of proteins in the same
experiment as D. #: protein levels below detection limit for the exposure time
analyzed. (F) HO-1 and Gapdh protein detected by Western blot in total kidney
(T), renal cortex (C), and renal medulla (M) of C57BL/6 mice, not infected (NI) or
7 d after Pcc infection. Data are representative of four mice per group in one
experiment. (G) Kidney immunostaining in C57BL/6 mice, not infected (NI) or
7 d after Pcc infection. Gamma glutamyl transferase 1 (Ggt1; red) was used as a
RPTEC marker. Image is representative of three mice per group in one exper-
iment. (Scale bar: 1,000 μm.) (H) Kidney immunostaining, as in G. DAPI (blue)
was used to counterstain DNA. Arrowheads highlight HO-1 (cyan) in Ggt1+
RPTEC. Images are representative of five random fields from four to six mice per
group in one experiment. (Scale bar: 50 μm.) P values in A and B, comparing
log-transformed heme concentration values, were determined using two-way
ANOVA with Tukey’s multiple comparisons tests, and in C and E using Mann–
Whitney U test. NS: not significant (P > 0.05); *P < 0.05; ***P < 0.001.
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as assessed by Western blotting (Fig. 3 A and B). This was also
the case in the kidney (Fig. 3 A and B), where we had previously
failed to detect Fth induction in response to Pcc infection (9),
most likely owing to technical reasons. Induction of Fth ex-
pression in the kidney occurred both in the cortex and the me-
dulla (Fig. 3 C and D and SI Appendix, Fig. S6A), predominantly
in RPTEC (Fig. 3E and SI Appendix, Fig. S6B).
FTH expression in RPTEC is essential to establish disease
tolerance to malaria. To assess whether FTH expression in
RPTEC contributes to the establishment of disease tolerance to
malaria, we generated FthPepckΔ/Δ mice, in which Fth is deleted
specifically in RPTEC (SI Appendix, Fig. S7A) (14). More than
75% of FthPepckΔ/Δ mice succumbed to Pcc infection, as com-
pared to 13.3% of control Pcc-infected Fthfl/fl mice (Fig. 4A).
This was not associated with changes in pathogen load (Fig. 4A),
suggesting that Fe storage by Fth in RPTEC is essential to es-
tablish disease tolerance to Pcc infection. Of note, Hmox1 ex-
pression was highly induced in the kidneys of Pcc-infected
FthPepckΔ/Δ vs. Fthfl/fl mice (SI Appendix, Fig. S7B), demonstrat-
ing that heme catabolism by Ho-1 per se fails to establish disease
tolerance to malaria, if not coupled to Fe storage by Fth.
Moreover, when considering Hmox1 induction as a biomarker of
cell stress, it becomes apparent that, in the absence of Fth, heme
catabolism by HO-1 is deleterious in RPTEC.
Pcc-infected FthPepckΔ/Δ mice developed AKI, as illustrated by
Lcn2, BUN, and cystatin C accumulation in plasma (Fig. 4B and
SI Appendix, Fig. S7C), compared with control Fthfl/fl mice. AKI
in Pcc-infected FthPepckΔ/Δ mice was associated with acute tu-
bular necrosis and intraluminal HB casts, affecting up to 40% of
the renal cortex, compared with control Pcc-infected Fthfl/fl mice
that developed only discrete and rare tubular epithelial cell ne-
crosis or HB casts in the renal cortex (Fig. 4C). Expression of
Lcn2 mRNA was also higher in the kidneys of Pcc-infected
FthPepckΔ/Δ vs. Fthfl/fl mice (SI Appendix, Fig. S7D).
The disease trajectories established by the temporal relationship
of body temperature vs. body weight vs. pathogen load showed
significant differences in Pcc-infected FthPepckΔ/Δ vs. Fthfl/fl mice
(Fig. 4 D and E), including before the onset of lethality. This
suggests that FTH expression in RPTEC is essential to main-
taining vital homeostatic factors such as body temperature and
body weight within a range compatible with host survival.
We have previously shown that composite Fth deletion in
FthMx1Δ/Δ mice compromises disease tolerance to Pcc infection
(9). This suggests that Fe storage by FTH, in cellular compart-
ments other than RPTEC, may contribute to disease tolerance to
malaria. However, Fth deletion in myeloid cells of FthLysMΔ/Δ
mice, hepatocytes of FthAlbΔ/Δ mice, or vascular endothelial cells
of FthCdh5Δ/Δ mice (SI Appendix, Fig. S8 A–E) failed to com-
promise disease tolerance to Pcc infection. This suggests that
deletion of Fth in the kidney (22) contributes critically to our
previous observation that FthMx1Δ/Δ mice fail to establish disease
tolerance to malaria (9).
FTH expression in RPTEC does not regulate local immune
responses. We asked whether FTH expression in RPTEC mod-
ulates kidney immunopathology, as assessed by renal leukocyte
infiltration. Neutrophils, inflammatory monocytes, and CD4+ as
well as CD8+ T cells accumulated to a similar extent in the
kidneys of Pcc-infected FthPepckΔ/Δ vs. Fthfl/fl mice (SI Appendix,
Fig. S9 A–F). The same was true for T cell proliferation, as
monitored by Ki67 expression (SI Appendix, Fig. S9 G–J). This
suggests that FTH expression in RPTEC does not impact on the
extent of kidney leukocyte infiltration.
FTH expression by RPTEC is not essential to establish disease
tolerance to hemolytic bacterial infections. Mortality from E. coli
CFT073 infection in FthPepckΔ/Δ was similar to that in Fthfl/fl mice
(SI Appendix, Fig. S10A). This suggests that, similarly to HO-1,
FtH expression in RPTEC is not required per se to provide a
survival advantage against infection by this hemolytic bacterium.
FTH is cytoprotective in RPTEC. We reasoned that FTH
might protect RPTEC from the cytotoxic effects of labile heme,
as it accumulates in plasma and urine during the blood stage of
Plasmodium infection (Fig. 1A). In keeping with previous find-
ings in other parenchyma cells (16, 23, 24), heme enhanced the
cytotoxic effect of hydrogen peroxide (H2O2) on human RPTEC
in vitro, compared with exposure to heme or H2O2 alone (Fig.
5A). Transduction of human RPTEC in vitro with a recombinant
adenovirus (Rec.Ad.) encoding FTH (Fig. 5B) was cytoprotective
against heme plus H2O2, compared with control cells transduced
with a Rec.Ad. encoding β-galactosidase (LacZ) (Fig. 5A). Hu-
man RPTEC were not protected against heme plus H2O2 when
transduced with a Rec.Ad. encoding a FTH mutant (FTHm)
lacking ferroxidase activity (Fig. 5 A and B) (9, 25), suggesting that
the ferroxidase activity of FTH is required to counter the cytotoxic
effects of labile heme and H2O2 in human RPTEC.
We then tested whether the cytoprotective effect of FTH is
mediated via a mechanism that prevents Fe from catalyzing the
production of reactive oxygen species (ROS). Human RPTEC
accumulated high levels of ROS when exposed in vitro to heme plus
H2O2, compared with heme or H2O2 alone (Fig. 5C). This is in
keeping with previous observations that heme promotes ROS
generation in parenchyma cells exposed to a variety of inflammatory
agonists (23, 24). Transduction of human RPTEC with an FTH, but
not an FTHm Rec.Ad., suppressed ROS accumulation, compared
with control cells transduced with a LacZ Rec.Ad. (Fig. 5 D and E).
This further supports the interpretation that the ferroxidase activity
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Fig. 2. HO-1 expression in RPTEC establishes disease tolerance to malaria. (A)
Survival and percentage of iRBC (mean ± SD) in Pcc-infected Hmox1fl/fl (n = 7)
and Hmox1PepcKΔ/Δ (n = 12) mice. Data from four independent experiments
with similar trend. (B) Lcn2 concentration in urine and BUN (mean ± SD) in
noninfected (NI) and Pcc-infected Hmox1PepcKΔ/Δ (NI: 5–11; Pcc: n = 7–12) and
Hmox1fl/fl (NI: n = 6–11; Pcc: n = 9–13) mice, 7 d after infection. Data from two
experiments with a similar trend. (C) Kidney H&E staining in noninfected and
7 d after Pcc infection. Representative of four to five mice per genotype in two
experiments. (Scale bar: 50 μm.) Arrowhead indicates HB casts, and dashed
lines outline tubular necrosis. (D) Individual disease trajectories of the same
mice as in A. Circles represent median of disease trajectories, and corre-
sponding numbers are days after infection (day 0). Portion of the disease
trajectories in darker color indicates days before onset of mortality in
Hmox1PepcKΔ/Δ mice. (E) The 3D plot of disease trajectories from the same mice
as in D. Statistical differences between genotypes became significant (P =
0.008; Mann–Whitney U test) on day 7 before onset of mortality in
Hmox1PepcKΔ/Δ mice. P values in A were determined using the log-rank
(Mantel–Cox) test and in B using two-way ANOVA with Tukey’s multiple
comparison test. NS, not significant (P > 0.05); ***P < 0.001.
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of FTH is critical to limit the pro-oxidant and cytotoxic effects of
intracellular labile Fe, generated via heme catabolism by HO-1 in
RPTEC. Presumably, this explains why, in the absence of FTH,
HO-1 fails to confer disease tolerance to malaria.
The transcription factor NRF2 controls the establishment of
disease tolerance to malaria. Upon activation NRF2 can induce
Hmox1 (26) and Fth (27), and therefore we asked whether NRF2
is required to support the induction of these genes in the kidneys
of Pcc-infected mice, preventing the development of AKI and
establishing disease tolerance. Expression of NAD(P)H quinone
dehydrogenase 1 (Nqo1), a prototypical NRF2-responsive gene
(28), was induced in the kidneys of Pcc-infected wild type
(Nrf2+/+) but not in Pcc-infected Nrf2-deficient (Nrf2−/−) mice
(Fig. 6A). This suggests that NRF2 is activated in the kidneys in
response to Pcc infection. Similar, although less pronounced, the
expression of Hmox1, Fth, and Ferroportin-1 (Fpn1; solute carrier
family 40 member 1; Slc40a1) was also induced in the kidney
during Pcc infection in Nrf2+/+ but to a lesser extent in Nrf2−/−
mice (Fig. 6A). This suggests that NRF2 activation in response to
Plasmodium infection supports the induction of HO-1, FTH, and
FPN1 in the kidney.
About 80% of Nrf2−/− mice succumbed to Pcc infection, com-
pared with 20% of control Pcc-infected Nrf2+/+mice (Fig. 6B), with
similar pathogen loads (Fig. 6C). Pcc-infected Nrf2−/− mice de-
veloped AKI, as illustrated by a higher BUN (Fig. 6D), and ex-
tensive acute tubular necrosis (Fig. 6E), compared with Nrf2+/+
mice. This suggests that NRF2 acts upstream of HO-1, FTH, and
FPN1 to promote the establishment of disease tolerance to malaria.
Given the involvement of other transcription factors, such as
the heat shock factor 1 (HSF1) (29) and hypoxia inducible factor
1 alpha (HIF1α) (30), in the regulation of HMOX-1 expression,
we addressed whether these transcription factors were also involved
in the establishment of disease tolerance to Pcc infection. To test this
hypothesis, we generated Hsf1R26Δ/Δ and Hif1αR26Δ/Δ mice, in which
Hsf1 or Hif1α, respectively, are globally deleted in an inducible
manner (SI Appendix, Fig. S11 A and B). Lethality and parasitemias
of Pcc-infected Hsf1R26Δ/Δ and Hif1αR26Δ/Δ mice were similar to
control Hsf1fl/fl and Hif1αfl/fl mice, respectively (SI Appendix, Fig.
S11 C–F). This suggests that neither HSF1 nor HIF1α are involved
in the establishment of disease tolerance to Pcc infection.
Discussion
Most of the Fe contained in the prosthetic heme groups of HB
must be continuously recycled, redirected toward heme biosynthesis,
and incorporated into nascent HB during erythropoiesis (31).
Hemophagocytic macrophages are at a center stage in this Fe-
recycling process, engulfing an estimated 2 × 106 senescent RBC
and processing 2 × 1015 heme molecules per second in healthy hu-
mans (31, 32). The pathologic outcomes associated with disruption
of this Fe-recycling process during hemolytic conditions are coun-
tered by the recruitment of circulating monocytes that differentiate
into tissue resident Fe-recycling hemophagocytic macrophages (33).
When the recruitment and differentiation of these macrophages is
impaired, hemolytic conditions become associated with the devel-
opment of AKI (33). Given that AKI is a hallmark of severe malaria
(10–12), it is reasonable to speculate that impairment of hemopha-
gocytic macrophage function (34) contributes to the pathogenesis of
malaria-associated AKI, but this remains to be formally established.
Presumably, defective hemophagocytic macrophage function
associated with malaria (34) also favors the accumulation of
damaged RBC in the circulation, leading to intravascular hemolysis
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marker. Image is representative of three mice per group in one experiment.
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Fig. 4. FTH expression in RPTEC is essential to establish disease tolerance to
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FthPepcKΔ/Δ (n = 23) and Fthfl/fl (n = 30) mice. Data are from six independent
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three experiments. (C) H&E staining of kidney sections from noninfected (NI)
and Pcc-infected FthPepcKΔ/Δ and Fthfl/fl mice, 9 d after infection. Arrowheads
indicate HB casts, and dashed lines outline tubular necrosis. Images are
representative of two to seven mice per genotype in four experiments. (Scale
bar: 50 μm.) (D) Individual disease trajectories of Pcc-infected FthPepcKΔ/Δ (n =
17) and Fthfl/fl (n = 10) mice from three independent experiments with a
similar trend. Circles represent median of disease trajectories, and corre-
sponding numbers indicate days after infection (day 0). Portion of disease
trajectories in darker color indicates days before onset of mortality in
FthPepcKΔ/Δ mice. (E) The 3D plot of disease trajectories from the same mice as
in D. Statistical differences between genotypes became significant on day 6
after Pcc infection (P = 0.00007; Mann–Whitney U test) before onset of mor-
tality of FthPepcKΔ/Δ mice. P values in A were determined using a log-rank
(Mantel–Cox) test and in B using two-way ANOVA with Tukey’s multiple
comparison test. NS, not significant; *P < 0.05; **P < 0.01; ***P < 0.001.
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and heme accumulation in plasma as well as in urine (Fig. 1 A and
B). Of note, labile heme accumulates at higher concentrations in
urine than in plasma (Fig. 1B), suggesting that the kidney actively
excretes heme during the blood stage of Plasmodium infection.
Labile heme is cytotoxic to RPTEC (Fig. 5 A, C, and D), likely
precipitating the development of AKI (13, 14). This pathologic
process is countered by the induction of HO-1 in RPTEC,
avoiding the development of AKI and establishing disease tol-
erance to malaria (Fig. 2 A–C). The observation that induction of
HO-1 in cell compartments other than RPTEC is not essential
per se to establish disease tolerance to malaria (SI Appendix, Fig.
S4) suggests that heme catabolism by HO-1 in RPTEC acts as a
limiting factor in the establishment of disease tolerance to
malaria. This does not exclude, however, HO-1 induction in
other organs, such as the liver (Fig. 1 C–E) (9), from contributing
to this defense strategy. However, in the absence of HO-1 ex-
pression by RPTEC, this is not sufficient to establish disease
tolerance to malaria (Fig. 2).
Our findings suggest that the Fe extracted from heme catab-
olism by HO-1 in RPTEC leads to the induction of ferritin (Fig.
3). In our previous work, however, we did not observe an in-
duction of Fth in the kidneys of Pcc-infected mice, likely owing
to technical reasons (9). Using different approaches, we have
now established unequivocally that the blood stage of Plasmodium
infection is associated with the induction of FTH in the kidneys
as well as in other organs such as the liver and skeletal and
cardiac muscle (Fig. 3 A and B). Moreover, we found that the
induction of FTH expression in the kidneys and, more specifi-
cally, in RPTEC (Fig. 3 C–E) is essential to prevent the devel-
opment of AKI and establish disease tolerance to malaria (Fig.
4). This is most likely because of the cytoprotective effect of FTH
(9, 23) that prevents RPTEC from undergoing programmed cell
death (Fig. 5) and suppresses the development of AKI (Fig. 4).
Our current findings are in keeping with our previous obser-
vation that composite deletion of Fth in FthMx1Δ/Δ mice (22)
compromises the establishment of disease tolerance to Plas-
modium infection (9), considering that Cre-mediated Fth de-
letion in Mx1Cre mice occurs in several organs including in the
kidneys (22). This suggests, however, that expression of Fth in
hepatocytes is not essential to establish disease tolerance to
malaria, as demonstrated using FthAlbΔ/Δ mice (SI Appendix, Fig.
S8B). This does not exclude, however, Fth expression in hepa-
tocytes or other parenchyma cells from contributing to the es-
tablishment of disease tolerance to malaria.
Our current finding that HO-1 and FTH expression in RPTEC
confers protection against malaria is also consistent with pre-
vious demonstrations of HO-1 and FTH induction in RPTEC
being protective against noninfectious hemolytic conditions, such
as warm antibody hemolytic anemia (35) and paroxysmal noc-
turnal hemoglobinuria (36). Moreover, others and we have
shown that HO-1 and FTH induction in RPTEC is also pro-
tective against different experimental models of heme-driven
kidney injury (13, 14). Finally, it is worth noting that global
deletion of Hmox1 in mice (37) and humans (38) is associated
with the development of kidney injury.
We have previously shown that sickle HB establishes disease
tolerance to malaria via a mechanism involving the induction of
HO-1 by the transcription factor NRF2 (2). The transcriptional
program orchestrated by NRF2 also induces the expression of
FTH (Fig. 6A), which is essential to confer disease tolerance to
the blood stage of Pcc infection (Fig. 6 B and C) (9), preventing
the pathogenesis of AKI (Fig. 6 D and E). This suggests there-
fore that the transcriptional program controlled by NRF2 in
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RPTEC is essential to prevent acute tubular necrosis underlying
the development of AKI.
As suggested by previous studies (18), the establishment of
disease tolerance to Pcc infection can be inferred from the
analyses of disease trajectories (Fig. 2 D and E and SI Appendix,
Figs. S3 and Fig. 4 D and E). Accordingly, Hmox1 or Fth deletion
in RPTEC gave rise to disease trajectories with a sharp decline of
body temperature, occurring irrespective of pathogen load (Figs.
2 D and E and 4 D and E). One possible explanation for why the
expression of these genes in the kidney controls body tempera-
ture likely relates to a cross-talk between Fe and glucose me-
tabolism in which intracellular Fe accumulation inhibits endogenous
glucose production via gluconeogenesis (25). Of note, kidney glu-
coneogenesis is essential to control of glycemia in response to dif-
ferent forms of stress (39), and glucose is a major source of energy
controlling thermoregulation and the establishment of disease tol-
erance to Plasmodium infection (40). We speculate that expression
of HO-1 and FTH in RPTEC might regulate kidney glucose pro-
duction in a manner that impacts on thermoregulation and the
establishment of disease tolerance to Plasmodium infection, which,
however, remains to be established.
In conclusion, this study demonstrates the existence of a previously
unsuspected tissue damage-control mechanism that operates specif-
ically in the kidneys to establish disease tolerance to Plasmodium
infection. We propose that targeting components of this defense
mechanism may be of therapeutic value in the treatment of severe
malaria without the selection of drug resistance in Plasmodium spp.
Materials and Methods
Plasmodium Infections. Mice were bred and maintained under specific
pathogen-free (SPF) conditions at the Instituto Gulbenkian de Ciência (IGC).
Experimental protocols were approved by the Ethics Committee of the IGC
(A008.2010 and A009.2011) and the Portuguese National Entity (Direcção
Geral de Alimentação e Veterinária; 008959 and 018071). Experimental
procedures were performed according to the Portuguese (Decreto-Lei 113/
2013) and European (Directive 2010/63/EU) legislations. Mice were infected
by i.p. inoculation of blood isolated from mice infected with a Pcc AS strain
[2 × 106 infected red blood cells (iRBC)]. Mice were monitored daily for
parasitemia, weight, temperature, RBC number, and survival.
Serology. Mice were killed and plasma was obtained at the indicated time
points after Plasmodium infection. BUN and aspartate aminotransferase (AST)
were quantified using quantitative colorimetric determination kits (Quanti-
Chrom and EnzyChrom; Bioassay Systems) and Lcn2 and Cystatin C by ELISA, as
detailed in SI Appendix.
Adenoviral Transduction in Human RPTEC. Human RPTEC (ScienCell Research
Laboratories) were transduced (50% confluence) with recombinant adeno-
virus encoding FTH, ferroxidase-deleted FTH, and LacZ, as described (9, 25).
Briefly, RPTEC were exposed to Rec.Ad. (10 pfu/cell, 6 h) and, within 48–72 h,
exposed to hemin (5 μM) and/or H2O2 (50 μM) and monitored for survival
and ROS production, as detailed in SI Appendix.
For detailed materials and methods, see SI Appendix.
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